Literature DB >> 8152431

Activating transcription factor-3 stimulates 3',5'-cyclic adenosine monophosphate-dependent gene expression.

H M Chu1, Y Tan, L A Kobierski, L B Balsam, M J Comb.   

Abstract

Activating transcription factor-3 (ATF-3) is one member of a large family of leucine zipper transcription factors which bind to promoters responsive to cAMP and phorbol ester at the related cAMP (CRE) and phorbol ester response elements. We report here that ATF-3 is coexpressed with the neuropeptide precursor proenkephalin in human neuroblastoma SK-N-MC cells. Cotransfection experiments indicate that activation of proenkephalin gene expression by ATF-3 is dependent upon both the catalytic subunit of the cAMP-dependent protein kinase and the CRE-2 element. The CRE-2 element is essential for second messenger-inducible expression and is known to bind AP-1-like transcription factors. ATF-3 expressed in bacteria or from rabbit reticulocyte lysates binds to the proenkephalin CRE-2 element as a homodimer and as a heterodimer with Jun-D, another activator of proenkephalin transcription. ATF-3 stimulates binding of Jun-D to the proenkephalin CRE-2 element and acts synergistically with Jun-D to induce proenkephalin gene expression. Sequential immunoprecipitations of ATF-3 from SK-N-MC cells expressing proenkephalin indicate that ATF-3 is complexed with Jun-D in vivo and that both proteins are highly phosphorylated. Together, our results suggest that ATF-3 may play an important role in the regulation of gene expression by cAMP-dependent intracellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152431     DOI: 10.1210/mend.8.1.8152431

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  21 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

2.  PhosphoCREB and CREM/ICER: positive and negative regulation of proenkephalin gene expression in the paraventricular nucleus of the hypothalamus.

Authors:  D Borsook; O Smirnova; O Behar; S Lewis; L A Kobierski
Journal:  J Mol Neurosci       Date:  1999-02       Impact factor: 3.444

Review 3.  Multiple transcription factor families regulate axon growth and regeneration.

Authors:  Darcie L Moore; Jeffrey L Goldberg
Journal:  Dev Neurobiol       Date:  2011-12       Impact factor: 3.964

4.  cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor.

Authors:  C S Narayanan; Y Cui; S Kumar; A Kumar
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

5.  FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2.

Authors:  Y Tan; J Rouse; A Zhang; S Cariati; P Cohen; M J Comb
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

6.  Interaction between Drosophila bZIP proteins Atf3 and Jun prevents replacement of epithelial cells during metamorphosis.

Authors:  Petra Sekyrova; Dirk Bohmann; Marek Jindra; Mirka Uhlirova
Journal:  Development       Date:  2010-01       Impact factor: 6.868

Review 7.  ATF3 transcription factor and its emerging roles in immunity and cancer.

Authors:  Matthew R Thompson; Dakang Xu; Bryan R G Williams
Journal:  J Mol Med (Berl)       Date:  2009-08-25       Impact factor: 4.599

8.  Fibroblast growth factor and cyclic AMP (cAMP) synergistically activate gene expression at a cAMP response element.

Authors:  Y Tan; K G Low; C Boccia; J Grossman; M J Comb
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

9.  Apoptosis-related genes change their expression with age and hearing loss in the mouse cochlea.

Authors:  Sherif F Tadros; Mary D'Souza; Xiaoxia Zhu; Robert D Frisina
Journal:  Apoptosis       Date:  2008-11       Impact factor: 4.677

10.  Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?

Authors:  Ying Guo; Elaine Johnson; William Cepurna; Lijun Jia; Jennifer Dyck; John C Morrison
Journal:  Exp Eye Res       Date:  2009-08-14       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.